Pharmacokinetic evaluation of β-lactam antibioticsDERENDORF, H.Journal of antimicrobial chemotherapy (Print). 1989, Vol 24, Num 3, pp 407-413, issn 0305-7453Article

Pharmacokinetic/pharmacodynamic consequences of space flightDERENDORF, H.Journal of clinical pharmacology. 1994, Vol 34, Num 6, pp 684-691, issn 0091-2700Article

HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY OF METHADONE, PHENYCLIDINE, AND METABOLITES BY POSTCOLUMN ION-PAIR EXTRACTION AND ON-LINE FLUORESCENT DETECTION OF THE COUNTERION WITH APPLICATIONSDERENDORF H; GARRETT ER.1983; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1983; VOL. 72; NO 6; PP. 630-635; BIBL. 13 REF.Article

Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safetyDERENDORF, H.Respiratory medicine. 1997, Vol 91, pp 22-28, issn 0954-6111, SUPAConference Paper

Erythrocyte binding of cephalosporinsDERENDORF, H.Journal of pharmacy and pharmacology. 1987, Vol 39, Num 2, pp 129-131, issn 0022-3573Article

CORTICAL-EVOKED POTENTIALS AND SALIVA LEVELS AS BASIS FOR THE COMPARISON OF PURE ANALGESIES TO ANALGESIC COMBINATIONSDERENDORF H; DREHSEN G; ROHDEWALD P et al.1982; PHARMACOLOGY; ISSN 0031-7012; CHE; DA. 1982; VOL. 25; NO 4; PP. 227-236; BIBL. 28 REF.Article

IN VIVO-IN VITRO CORRELATIONS OF SALICYLATE SALIVA LEVELS AND CONTINUOUS FLOW CELL DISSOLUTION RATESDERENDORF H; DREHSEN G; ROHDEWALD P et al.1983; INTERNATIONAL JOURNAL OF PHARMACEUTICS; ISSN 0378-5173; NLD; DA. 1983; VOL. 15; NO 2; PP. 167-175; BIBL. 11 REF.Article

Molecular and clinical pharmacology of intranasal corticosteroids : clinical and therapeutic implicationsDERENDORF, H; MELTZER, E. O.Allergy (Copenhagen). 2008, Vol 63, Num 10, pp 1292-1300, issn 0105-4538, 9 p.Article

Local treatment of respiratory infections with antibioticsSTOUT, S. A; DERENDORF, H.Drug intelligence & clinical pharmacy. 1987, Vol 21, Num 4, pp 322-329, issn 0012-6578Article

RELATIONSHIP BETWEEN SALIVA LEVELS OF METAMIZOL METABOLITES, BIOAVAILABILITY AND ANALGESIC EFFICACYROHDEWALD P; DREHSEN G; MILSMANN E et al.1983; ARZNEIMITTEL-FORSCHUNG; ISSN 0004-4172; DEU; DA. 1983; VOL. 33; NO 7; PP. 985-988; ABS. GER; BIBL. 22 REF.Article

Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships : Concepts and perspectivesDERENDORF, H; MEIBOHM, B.Pharmaceutical research. 1999, Vol 16, Num 2, pp 176-185, issn 0724-8741Article

Pitfalls in pharmacokinetic multicompartment analysisLIANG, E; DERENDORF, H.Journal of pharmacokinetics and biopharmaceutics. 1998, Vol 26, Num 2, pp 247-260, issn 0090-466XArticle

Rapid analysis of ranitidine in biological fluids and determination of its erythrocyte partitioningMULLERSMAN, G; DERENDORF, H.Journal of chromatography. 1986, Vol 381, Num 2, pp 385-391, issn 0021-9673Article

Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairmentDERENDORF, H; DALLA COSTA, T.International journal of clinical pharmacology and therapeutics. 1996, Vol 34, Num 11, pp 482-488, issn 0946-1965Conference Paper

Coulometric high-performance liquid chromatographic analysis of morphine in biological fuidsDERENDORF, H; KALTENBACH, M.Journal of pharmaceutical sciences. 1986, Vol 75, Num 12, pp 1198-1200, issn 0022-3549Article

CHANGES IN CORTICAL EVOKED POTENTIALS AS CORRELATES OF THE EFFICACY OF WEAK ANALGESISROHDEWALD P; DERENDORF H; DREHSEN G et al.1982; PAIN (AMST.); ISSN 0304-3959; NLD; DA. 1982; VOL. 12; NO 4; PP. 329-341; BIBL. 26 REF.Article

Pharmacokinetic properties of β-lactamase inhibitorsDE LA PENA, A; DERENDORF, H.International journal of clinical pharmacology and therapeutics. 1999, Vol 37, Num 2, pp 63-75, issn 0946-1965Article

Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjectsYOST, R. L; DERENDORF, H.Therapeutic drug monitoring. 1986, Vol 8, Num 2, pp 189-194, issn 0163-4356Article

Rapid chromatographic determination of cefotaxime and its metabolite in biological fluidsYOST, R. L; DERENDORF, H.Journal of chromatography. 1985, Vol 341, Num 1, pp 131-138, issn 0021-9673Article

Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinationsLIU, Q; RAND, K; DERENDORF, H et al.International journal of antimicrobial agents. 2004, Vol 23, Num 5, pp 494-497, issn 0924-8579, 4 p.Article

HPLC analysis of buprenorphine in plasma and urine using coulometric detectionMULLERSMAN, G; TOUFFLIN, S; DERENDORF, H et al.Journal of pharmaceutical and biomedical analysis. 1987, Vol 5, Num 3, pp 303-308, issn 0731-7085Article

Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogsGARRETT, E. R; DERENDORF, H; MATTHA, A. G et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 11, pp 1203-1214, issn 0022-3549Article

A review of the effects of chronic exercise and physical fitness level on resting pharmacokineticsPERSKY, A. M; EDDINGTON, N. D; DERENDORF, H et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 11, pp 504-516, issn 0946-1965, 13 p.Article

Gender differences in pharmacokinetics and pharmacodynamicsBEIERLE, I; MEIBOHM, B; DERENDORF, H et al.International journal of clinical pharmacology and therapeutics. 1999, Vol 37, Num 11, pp 529-547, issn 0946-1965Article

Pharmacokinetic and pharmacodynamic changes in the elderly clinical implicationsHÄMMERLEIN, A; DERENDORF, H; LOWENTHAL, D. T et al.Clinical pharmacokinetics. 1998, Vol 35, Num 1, pp 49-64, issn 0312-5963Article